drugset
drugset / Trial / NCT00381264

Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Multiple Sclerosis

NCT00381264 ↗

Phase 4 Completed 23 enrolled NEMA Research, Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study was designed to evaluate the safety and efficacy of Cesamet™ in controlling pain in subjects experiencing pain due to Multiple Sclerosis.

Timeline

Start
2006-09
Primary completion
2007-10
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Nabilone Other / unclassified — —

Indications

multiple sclerosis